相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Significant inter- and intra-laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands
Carmen van Dooijeweert et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
Tomas Pascual et al.
FRONTIERS IN ONCOLOGY (2019)
FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma
Jingchao Wang et al.
ONCOGENE (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
ELMER v.2: an R/Bioconductor package to reconstruct gene regulatory networks from DNA methylation and transcriptome profiles
Tiago C. Silva et al.
BIOINFORMATICS (2019)
Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data
Tamara Diaz-Redondo et al.
FRONTIERS IN ONCOLOGY (2019)
Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
Kamal Pandey et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value
Angela Santoro et al.
CELL REPORTS (2019)
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
Bradley A. Hancock et al.
BREAST CANCER RESEARCH (2019)
PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective
Lee A. D. Cooper et al.
JOURNAL OF PATHOLOGY (2018)
DNA methylation loss in late-replicating domains is linked to mitotic cell division
Wanding Zhou et al.
NATURE GENETICS (2018)
In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor
Andrea Vaupel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi et al.
CANCER CELL (2018)
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Jennifer K. Litton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The molecular basis of breast cancer pathological phenotypes
Yujing J. Heng et al.
JOURNAL OF PATHOLOGY (2017)
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Matthew P. Goetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells
Shuping Yin et al.
PLOS ONE (2017)
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
Giampaolo Bianchini et al.
BREAST CANCER RESEARCH (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial
M. V. Dieci et al.
ANNALS OF ONCOLOGY (2016)
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
Luca Gianni et al.
LANCET ONCOLOGY (2016)
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
G. N. Hortobagyi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A microscopic landscape of the invasive breast cancer genome
Zheng Ping et al.
SCIENTIFIC REPORTS (2016)
Determining breast cancer histological grade from RNA-sequencing data
Mei Wang et al.
BREAST CANCER RESEARCH (2016)
Clinical implications of the intrinsic molecular subtypes of breast cancer
Aleix Prat et al.
BREAST (2015)
Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
Suzanne A. W. Fuqua et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
Laxmi Silwal-Pandit et al.
CLINICAL CANCER RESEARCH (2014)
Mutational signatures: the patterns of somatic mutations hidden in cancer genomes
Ludmil B. Alexandrov et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Mechanisms underlying mutational signatures in human cancers
Thomas Helleday et al.
NATURE REVIEWS GENETICS (2014)
PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data
Dimitrios Zardavas et al.
BREAST CANCER RESEARCH (2014)
Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways
Stina M. Singel et al.
BREAST CANCER RESEARCH (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Steven A. Roberts et al.
NATURE GENETICS (2013)
Taxane benefit in breast cancer-a role for grade and chromosomal stability
Roger P. A'Hern et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Whole-genome analysis informs breast cancer response to aromatase inhibition
Matthew J. Ellis et al.
NATURE (2012)
Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains
Benjamin P. Berman et al.
NATURE GENETICS (2012)
Mechanisms of the hepatoprotective effects of tamoxifen against drug-induced and chemical-induced acute liver injuries
Yukitaka Yoshikawa et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer
Hiroyuki Yasojima et al.
EUROPEAN JOURNAL OF CANCER (2011)
Increased methylation variation in epigenetic domains across cancer types
Kasper Daniel Hansen et al.
NATURE GENETICS (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade
Britta Weigelt et al.
JOURNAL OF PATHOLOGY (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Breast cancer prognostic classification in the molecular era: the role of histological grade
Emad A. Rakha et al.
BREAST CANCER RESEARCH (2010)
Competing Risk Regression Models for Epidemiologic Data
Bryan Lau et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2008)
Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes
Emad A. Rakha et al.
EUROPEAN JOURNAL OF CANCER (2008)
Prognostic significance of Nottingham histologic grade in invasive breast carcinoma
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Pratyaksha Wirapati et al.
BREAST CANCER RESEARCH (2008)
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
Rameen Beroukhim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Biologic and clinical characteristics of breast cancer with single hormone receptor-positive phenotype
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Dietary fat reduction and breast cancer outcome: Interim efficacy results from the Women's Intervention Nutrition Study
Rowan T. Chlebowski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
